CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) inhibitors are not equally effective in all cancer patients. One potential clinical factor that could help in selecting patients who may benefit from treatment with cetuximab is acneiform rash, which correlates with the clinical respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarząbek, Tomasz, Rucińska, Monika, Rogowski, Wojciech, Lewandowska, Marzena, Tujakowski, Jerzy, Habib, Maja, Kowalczyk, Anna, Byszek, Agnieszka, Dziadziuszko, Rafał, Nawrocki, Sergiusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555232/
https://www.ncbi.nlm.nih.gov/pubmed/25721848
http://dx.doi.org/10.1007/s40291-015-0132-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555232/
https://www.ncbi.nlm.nih.gov/pubmed/25721848
http://dx.doi.org/10.1007/s40291-015-0132-9

Ejemplares similares